BOVIE MEDICAL CORP (BVX) is a publicly traded company in the Unknown sector. Across all available filings, 13 corporate insiders have executed 134 transactions totaling $4.2M, demonstrating a bearish sentiment with -$1.7M in net insider flow. The most recent transaction on Nov 8, 2018 involved a transaction of 2,000 shares valued at $13.7K.
No significant insider buying has been recorded for BVX in the recent period.
No significant insider selling has been recorded for BVX in the recent period.
Based on recent SEC filings, insider sentiment for BVX is bearish with an Insider Alignment Score of 30/100 and a net flow of -$1.7M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at BOVIE MEDICAL CORP (BVX) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 13 insiders are actively trading BVX stock, having executed 134 transactions in the past 90 days. The most active insider is Andrew Makrides (Executive), who has made 28 transactions totaling $1.8M.
Get notified when executives and directors at BVX file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Nov 8, 2018 | Makrides Andrew | Executive | Gift | 2,000 | $6.84 | $13.7K | |
| Nov 8, 2018 | Makrides Andrew | Executive | Gift | 2,000 | $6.84 | $13.7K | |
| Nov 8, 2018 | Makrides Andrew | Executive | Gift | 2,000 | $6.84 | $13.7K | |
| Aug 17, 2016 | J. Mccarthy John III | Executive | Purchase | 90,750 | $3.30 | $299.5K | |
| Dec 22, 2015 | J. Mccarthy John III | Executive | Purchase | 25,000 | $1.98 | $49.5K | |
| Dec 21, 2015 | Gershon Robert | Executive | Purchase | 10,000 | $1.82 | $18.2K | |
| Dec 21, 2015 | Citronowicz Moshe | Executive | Purchase | 20,000 | $1.84 | $36.8K | |
| Aug 14, 2015 | Gershon Robert | Executive | Purchase | 20,000 | $2.39 | $47.8K | |
| Mar 17, 2015 | Partners Llc Great Point | Executive | Award | 480,000 | $2.50 | $1.2M | Large |
| Sep 19, 2014 | Makrides Andrew | Executive | Option Exercise | 25,000 | $2.13 | $53.3K | |
| Sep 19, 2014 | Makrides Andrew | Executive | Payment | 12,241 | $4.35 | $53.2K | |
| Sep 19, 2014 | Robert Saron J. | Executive | Option Exercise | 12,500 | $2.13 | $26.6K | |
| Sep 19, 2014 | Robert Saron J. | Executive | Payment | 6,121 | $4.35 | $26.6K | |
| Oct 1, 2013 | W. Kromer George | Executive | Gift | 4,000 | $2.91 | $11.6K | |
| Dec 5, 2012 | W. Kromer George | Executive | Gift | 5,000 | $2.65 | $13.3K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 47 | $3.0M | 37.1% |
Award(A) | 3 | $1.3M | 15.9% |
Purchase(P) | 15 | $1.3M | 15.6% |
Payment(F) | 15 | $881.9K | 11.0% |
Exercise (Options)(X) | 13 | $797.3K | 9.9% |
Exercise(M) | 19 | $623.1K | 7.7% |
Gift(G) | 22 | $224.2K | 2.8% |
Insider selling pressure at BOVIE MEDICAL CORP has increased, with 13 insiders executing 134 transactions across all time. Total sales of $3.0M significantly outpace purchases of $1.3M, resulting in a net outflow of $1.7M. This selling activity appears largely discretionary, which may warrant closer attention from investors.